Please assess the completion status of the following clinical trial:

Trial Title: Experimental Study to Determine the Effects of Human Refluxate on Macrophage Phenotype and Its Correlation With GERD

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~Clinical (patients) part~1. Signed informed consent~2. Gender: Male or Female~3. Age: 18-65 years of age~3. Clinically and/or endoscopically confirmed diagnosis of GERD~Exclusion Criteria:~Clinical: (patient)~1. Current treatment with proton pump inhibitors and/or histamine-2 receptor antagonists. These treatments should have been stopped at least 1 week prior to study inclusion.~2. Female patients who are pregnant, planning to become pregnant or lactating~3. Any acute diseases or conditions, exacerbations of concomitant chronic diseases (including but not limited to inflammatory bowel disease (IBD), ulcer disease etc.) at study start/inclusion and/or which are not resolved 14 days prior to study-enrolment.~4. Participation in a clinical trial in the past 3 months~5. Any condition which, in the opinion of investigator, makes the patient unsuitable for participation in the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- NERD patients (Type: EXPERIMENTAL): Patients have typical reflux syndrome without esophageal injury.
- EE patients (Type: EXPERIMENTAL): Patients have erosion(s) or ulcer(s) in esophagus.
- BE patients (Type: EXPERIMENTAL): Patients have esophageal specialized intestinal metaplasia.

Based on this trial design, predict the completion outcome and termination type (if applicable).